Axis Bio is a preclinical contract research organisation with specialist capabilities in oncology, inflammation and respiratory diseases. We offer bespoke scientific models to test novel therapeutics used in the treatment of illnesses including, but not limited to, breast cancer, lung cancer, prostate cancer, arthritis and COPD. Services range from in vitro efficacy and mechanistic studies to in vivo target engagement, with each study tailored to the unique requirements of the client. Our clients are spread across the globe and include pharmaceutical and biotech businesses, university-based research organisations and virtual/semi-virtual development companies.
